Boston Scientific Corporation (US) and Novatech SA (France) are Leading Market Players in the Airway Stent/Lung Stent Market
The global airway stent/lung stent market is projected to reach USD 120 million by 2024 from USD 87 million in 2019, at a CAGR of 6.7%. In 2018, Boston Scientific Corporation (US) and Novatech SA (France) ranked as the top two players in the airway stent/lung stent market. Boston Scientific Corporation (US ) dominated the airway stent/lung stent market in 2018. Pulmonary/airway/lung stents such as Ultraflex, Dynamic, and Polyflex offered by Boston Scientific has set a benchmark in the market. Boston Scientific achieved significant growth in 2018 compared to 2016, owing to its strong growth in product development and increasing success in gaining market approvals. The company has a strong presence in over 40 countries across North America, Europe, the Asia Pacific, and the Middle East & Africa. The company is also focused on expanding its business in emerging markets through the development of distribution networks in countries such as India, China, and Latin America. To...